BLAM
Bourne Lent Asset Management Portfolio holdings
AUM
$258M
This Quarter Return
+12.22%
1 Year Return
+11.26%
3 Year Return
+79.24%
5 Year Return
+149.9%
10 Year Return
+528.55%
AUM
$212M
AUM Growth
+$212M
(+1.8%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-5.45%
Top 10 Holdings %
Top 10 Hldgs %
75.52%
Holding
61
New
4
Increased
13
Reduced
13
Closed
1
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
$26.7M |
| 2 |
Enbridge
ENB
|
$536K |
| 3 |
L3Harris
LHX
|
$495K |
| 4 |
Amazon
AMZN
|
$462K |
| 5 |
Illumina
ILMN
|
$431K |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
$41.3M |
| 2 |
Idexx Laboratories
IDXX
|
$172K |
| 3 |
GE Aerospace
GE
|
$164K |
| 4 |
Verizon
VZ
|
$126K |
| 5 |
Pfizer
PFE
|
$125K |
Sector Composition
| 1 | Technology | 40.99% |
| 2 | Healthcare | 33.84% |
| 3 | Communication Services | 10.02% |
| 4 | Consumer Discretionary | 4.46% |
| 5 | Industrials | 3.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Adobe
ADBE
$151B
| $31.8M | 14.99% | 96,465 | – | – |
|
|
2
Bristol-Myers Squibb
BMY
$96B
| $27.1M | 12.78% | 422,735 +415,315 | +5,597% | +$26.7M |
|
|
3
Idexx Laboratories
IDXX
$51.8B
| $23.6M | 11.13% | 90,522 -660 | -0.7% | -$172K |
|
4
Microsoft
MSFT
$3.77T
| $18.7M | 8.81% | 118,662 -72 | -0.1% | -$11.4K |
|
5
Apple
AAPL
$3.45T
| $15.1M | 7.09% | 51,271 -287 | -0.6% | -$84.3K |
|
6
Intuitive Surgical
ISRG
$170B
| $10.1M | 4.76% | 17,103 | – | – |
|
7
Alphabet (Google) Class C
GOOG
$2.58T
| $9.43M | 4.44% | 7,054 -8 | -0.1% | -$10.7K |
|
|
8
Alphabet (Google) Class A
GOOGL
$2.57T
| $8.78M | 4.14% | 6,556 | – | – |
|
9
Paychex
PAYX
$50.2B
| $7.83M | 3.69% | 92,095 -200 | -0.2% | -$17K |
|
10
Cisco
CSCO
$274B
| $7.83M | 3.69% | 163,264 +2,918 | +2% | +$140K |
|
11
Booking.com
BKNG
$181B
| $4.42M | 2.08% | 2,150 | – | – |
|
|
12
Amazon
AMZN
$2.44T
| $4.07M | 1.92% | 2,205 +250 | +13% | +$462K |
|
13
Qualcomm
QCOM
$173B
| $3.81M | 1.8% | 43,203 | – | – |
|
14
United Parcel Service
UPS
$74.1B
| $3.24M | 1.53% | 27,694 +200 | +0.7% | +$23.4K |
|
|
15
Enbridge
ENB
$105B
| $2.69M | 1.27% | 67,697 +13,475 | +25% | +$536K |
|
16
Johnson & Johnson
JNJ
$427B
| $2.43M | 1.14% | 16,651 | – | – |
|
17
T Rowe Price
TROW
$23.6B
| $2.43M | 1.14% | 19,910 -50 | -0.3% | -$6.09K |
|
18
Pacific Biosciences
PACB
$393M
| $2.27M | 1.07% | 441,650 | – | – |
|
19
AT&T
T
$209B
| $2.26M | 1.06% | 57,868 +10,301 | +22% | +$402K |
|
20
Tompkins Financial
TMP
$1.01B
| $2.07M | 0.98% | 22,650 +2,000 | +10% | +$183K |
|
21
Quanta Services
PWR
$56.3B
| $1.86M | 0.88% | 45,775 +25 | +0.1% | +$1.02K |
|
22
Nutrien
NTR
$28B
| $1.86M | 0.87% | 38,712 -80 | -0.2% | -$3.83K |
|
23
Amgen
AMGN
$155B
| $1.25M | 0.59% | 5,187 +300 | +6% | +$72.3K |
|
24
Visa
V
$683B
| $1.22M | 0.58% | 6,500 | – | – |
|
|
25
Pfizer
PFE
$141B
| $1.1M | 0.52% | 27,979 -3,180 | -10% | -$125K |
|